MeiraGTx Holdings PLC
Change company Symbol lookup
Select an option...
MGTX MeiraGTx Holdings PLC
LOTZ Carlotz Inc
NVSAW New Vista Acquisition Corp *W EXP 02/01/2026
ARAY Accuray Inc
GE General Electric Co
NRG NRG Energy Inc
CYD China Yuchai International Ltd
FST FAST Acquisition Corp
AAPL Apple Inc
AMZN Amazon.com Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

MeiraGTx Holdings plc is a clinical-stage gene therapy company. The Company develops gene therapy treatments for a range of inherited and acquired disorders. It is focused on developing therapies for ocular diseases, including rare inherited blindness, as well as Xerostomia, radiation treatment for head and neck cancers and neurodegenerative diseases, such as amyothrophic lateral sclerosis (ALS). It is also developing transformative technology to enable the use of small molecules to turn gene therapy product candidates on and off. It is focused on three areas of unmet medical needs, including inherited retinal diseases, severe forms of xerostomia and neurodegenerative diseases. Its product candidates include AAV-CNGB3, AAV-CNGA3, AAV-RPGR, AAV-RPE65, AAV-AQP1 and AAV-UPF1.

Postmarket

Last Trade
Delayed
$20.96
-0.02 (-0.10%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$20.98
Day's Change
-0.01 (-0.05%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
22.22
Day's Low
20.35
Volume
(Light)
Volume:
761,398

10-day average volume:
1,102,455
761,398

Nearly 70% of big U.S. companies are adopting a flexible work model, says Morgan Stanley

5:04 pm ET October 5, 2021 (MarketWatch)
Print

By Joy Wiltermuth

What's the 'ego revolution'? Companies planning out office space may want to find out

What does the future of work look like? It likely won't involve a commute to the office five days a week for employees at Fortune 500 companies, even after the threat of the coronavirus fades.

That's a key takeaway from a Morgan Stanley report tracking the return to office plans of 61 major U.S. public companies, with a combined market capitalization of about $15 trillion.

"Our analysis suggests 69% of corporations are adopting a hybrid structure such as 3 days in and 2 days WFH," Ronald Kamdem's team of equity analysts and researchers at Morgan Stanley, wrote in the Tuesday report, which tracked corporate data and policies through for the third quarter.

Only 10% indicated a preference for office work, when examining the evolving policies during the pandemic in seven industries, including Apple Inc., (AAPL) Amazon.com Inc. (AMZN), Facebook Inc. (FB), Uber Technologies Inc.(UBER), Yelp Inc. (YELP) and more.

The surge of the delta variant among the unvaccinated stalled plans by many companies to recall more staff around Labor Day or later this year, even though the latest wave of U.S. infections and hospitalizations appears to have peaked.

Read: Positive news on COVID-19 vaccines and treatments in the U.S. weighs against Russia's latest record one-day death toll

State of the office

While it's too early to write the final chapter on how the pandemic changed corporate America and its physical office space, it won't likely be a return to business-as-usual.

The upheaval of the pandemic has led millions of workers to quit their jobs as part of the "Great Resignation," with some opting to retire, but others looking for a shorter commute, higher pay or greater flexibility on the job.

Global real-estate firm Jones Lang LaSalle (JLL) called it the "ego revolution" in a recent report on the workplace, noting the drawbacks of endless workdays from home and lack of face-to-face interactions, but also that "finding the right mix of home and office work is the obvious answer."

To be sure, only about 34% of the companies had begun returning staff to the office in some capacity as of the third quarter, per Morgan Stanley, a figure that roughly matches Kastle Systems' most recent 10-city average office occupancy report.

Morgan Stanley analysts expect that figure to grow to 70% by the end of March 2022, or two years after nationwide lockdowns first took hold in the U.S. to contain COVID's spread, but they also pegged another 30% of companies with protracted or no plans to return staff to offices.

Coming up: 2-year mark

With plenty of change and uncertainty afoot, the future of office buildings still needs time to take shape.

Values of U.S. office buildings were pegged as 6% below pre-COVID levels as of August, whereas they climbed 8% higher for all property types for the same stretch, according to the Green Street Commercial Property Price Index.

But those figures also rely on depressed sales activity during the pandemic so far, with many on Wall Street expecting to get a better picture of property values and office leasing activity next year as the return to office gathers steam.

The spark of office life has returned more quickly in some cities, including Austin, Texas, than others like San Francisco, a reminder that real estate always boils down to location.

For example, San Francisco's high 26% office availability rate and discounted prices -- even in trophy buildings -- come as large, tech-related companies led almost 2 million square feet of new leased office space in the third quarter, which was above its 5-year quarterly average, according to Savills Research.

Shares for many office REITS were up about 13% to 17.5% on the year, including for Boston Properties Inc., (BXP) Hudson Pacific Properties Inc., (HPP) Office Properties Income Trust (OPI), and Vornado Realty Trust (VNO), even though prices remained depressed from those of two years ago, according to FactSet data.

While the S&P 500 index was up almost 45% on Tuesday from two years ago, shares of Office Properties Income, which focuses on renting its buildings to single tenants, including government entities, were down about 15% on Tuesday from two years ago.

The REITs didn't immediately respond to requests for comment.

Read: European bank adds Philadelphia suburb hub to its 'office as a destination' strategy

-Joy Wiltermuth

	

(END) Dow Jones Newswires

October 05, 2021 17:04 ET (21:04 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2021. All rights reserved.